Literature DB >> 7805134

Synthesis of artificial glycoconjugates of arginine-vasopressin and their antidiuretic activities.

H Susaki1, K Suzuki, M Ikeda, H Yamada, H K Watanabe.   

Abstract

Arginine-vasopressin (AVP) derivatives modified at the glutamine side chain amide with carbohydrate via an alkylene spacer (1a--d) were synthesized from new glycosylated glutamine derivatives (3a--d) by solid-phase synthesis. Glycoconjugates of AVP modified at the C-terminal amide (2a--d) were also synthesized from vasopressionic acid. All of them exhibited antidiuretic activity.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7805134     DOI: 10.1248/cpb.42.2090

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  3 in total

1.  Structural requirements for alkylglycoside-type renal targeting vector.

Authors:  K Suzuki; T Ando; H Susaki; K Mimori; S Nakabayashi; Y Sugiyama
Journal:  Pharm Res       Date:  1999-07       Impact factor: 4.200

2.  Peptide and antibody ligands for renal targeting: nanomedicine strategies for kidney disease.

Authors:  Jonathan Wang; Jacqueline J Masehi-Lano; Eun Ji Chung
Journal:  Biomater Sci       Date:  2017-07-25       Impact factor: 6.843

Review 3.  The potential of RNA-based therapy for kidney diseases.

Authors:  Tjessa Bondue; Lambertus van den Heuvel; Elena Levtchenko; Roland Brock
Journal:  Pediatr Nephrol       Date:  2022-05-04       Impact factor: 3.651

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.